NASDAQ: ALZN
Alzamend Neuro Inc Stock Ownership - Who owns Alzamend Neuro?

Insider buying vs selling

Have Alzamend Neuro Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Milton C. Ault IiiDirector2025-12-231,851$2.07
$3.83kSell
William B. HorneDirector2025-12-193,333$2.12
$7.06kSell
Lynne Fahey McGrathDirector2025-10-2330$2.29
$68.70Sell
Milton C. Ault IiiDirector2025-10-0920,397$2.32
$47.38kSell
Milton C. Ault IiiDirector2025-10-0861,743$2.32
$143.24kBuy
Milton C. Ault IiiDirector2025-10-08101,394$2.44
$247.20kSell
Milton C. Ault IiiDirector2025-10-07100,000$2.32
$232.00kBuy
Milton C. Ault IiiDirector2025-10-0757,379$2.49
$142.93kSell
Milton C. Ault IiiDirector2025-10-0682,033$2.45
$201.31kSell
Milton C. Ault IiiDirector2025-10-0365,903$2.44
$160.87kSell

1 of 5

ALZN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ALZN insiders and whales buy or sell their stock.

ALZN Shareholders

What type of owners hold Alzamend Neuro Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Milton C. Ault Iii920.80%35,005,072$77.01MInsider
Jeffrey Oram2.63%100,000$220.00kInsider
Andrew H. Woo2.63%100,000$220.00kInsider
Drw Securities LLC2.40%91,245$200.74kInstitution
Mark Gustafson1.58%60,000$132.00kInsider
Stephan Jackman1.20%45,500$100.10kInsider
Vanguard Group Inc0.57%21,620$47.56kInstitution
Geode Capital Management LLC0.54%20,578$45.27kInstitution
Clearstead Advisors LLC0.26%10,000$22.00kInstitution
David J. Katzoff0.15%5,540$12.19kInsider

1 of 2

ALZN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ALZN0.42%99.58%Net BuyingNet Selling
APVO12.10%87.90%Net BuyingNet Buying
BCTX0.28%99.72%
KPRX4.80%95.20%
RNAZ0.41%99.59%

Alzamend Neuro Stock Ownership FAQ

Who owns Alzamend Neuro?

Alzamend Neuro (NASDAQ: ALZN) is owned by 3.88% institutional shareholders, 928.98% Alzamend Neuro insiders, and 0.00% retail investors. Milton C. Ault Iii is the largest individual Alzamend Neuro shareholder, owning 35.01M shares representing 920.80% of the company. Milton C. Ault Iii's Alzamend Neuro shares are currently valued at $77.01M.

If you're new to stock investing, here's how to buy Alzamend Neuro stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.